| Prevalence of HBsAg among Moroccan HIV-1 infected patients and APOBEC3G variant frequencies in HIV-1/HBV co-infection. | Prevalence of HBsAg among Moroccan HIV-1 infected patients and APOBEC3G variant frequencies in HIV-1/HBV co-infection.
Belbacha I, Bensghir R, Filali Marhoum K, Laboudi M, Hajoutt K, Elharti E, Sadki K, Oumzil H. | 06/25/2024 |
| Regulatory variants of APOBEC3 genes potentially associate with COVID-19 severity in populations with African ancestry. | Regulatory variants of APOBEC3 genes potentially associate with COVID-19 severity in populations with African ancestry.
Zhang K, Chen F, Shen HY, Zhang PP, Gao H, Peng H, Luo YS, Cheng ZS., Free PMC Article | 04/2/2024 |
| HIV-1 Vif protein sequence variations in South African people living with HIV and their influence on Vif-APOBEC3G interaction. | HIV-1 Vif protein sequence variations in South African people living with HIV and their influence on Vif-APOBEC3G interaction.
Williams ME., Free PMC Article | 01/30/2024 |
| APOBEC3G Is a p53-Dependent Restriction Factor in Respiratory Syncytial Virus Infection of Human Cells Included in the p53/Immune Axis. | APOBEC3G Is a p53-Dependent Restriction Factor in Respiratory Syncytial Virus Infection of Human Cells Included in the p53/Immune Axis.
Gladwell W, Yost O, Li H, Bell WJ, Chen SH, Ward JM, Kleeberger SR, Resnick MA, Menendez D., Free PMC Article | 12/20/2023 |
| Keratinocytes sense and eliminate CRISPR DNA through STING/IFN-kappa activation and APOBEC3G induction. | Keratinocytes sense and eliminate CRISPR DNA through STING/IFN-κ activation and APOBEC3G induction.
Sarkar MK, Uppala R, Zeng C, Billi AC, Tsoi LC, Kidder A, Xing X, Perez White BE, Shao S, Plazyo O, Sirobhushanam S, Xing E, Jiang Y, Gallagher KA, Voorhees JJ, Kahlenberg JM, Gudjonsson JE., Free PMC Article | 05/8/2023 |
| APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage. | APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage.
Britan-Rosich Y, Ma J, Kotler E, Hassan F, Botvinnik A, Smith Y, Moshel O, Nasereddin A, Sharma G, Pikarsky E, Ross S, Kotler M., Free PMC Article | 04/7/2023 |
| The structural basis for HIV-1 Vif antagonism of human APOBEC3G. | The structural basis for HIV-1 Vif antagonism of human APOBEC3G.
Li YL, Langley CA, Azumaya CM, Echeverria I, Chesarino NM, Emerman M, Cheng Y, Gross JD., Free PMC Article | 03/24/2023 |
| The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer. | The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.
Liu W, Newhall KP, Khani F, Barlow L, Nguyen D, Gu L, Eng K, Bhinder B, Uppal M, Récapet C, Sboner A, Ross SR, Elemento O, Chelico L, Faltas BM. | 03/2/2023 |
| Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners. | Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners.
Zhao S, Zheng B, Wang L, Cui W, Jiang C, Li Z, Gao W, Zhang W., Free PMC Article | 02/11/2023 |
| Structural basis for HIV-1 antagonism of host APOBEC3G via Cullin E3 ligase. | Structural basis for HIV-1 antagonism of host APOBEC3G via Cullin E3 ligase.
Ito F, Alvarez-Cabrera AL, Liu S, Yang H, Shiriaeva A, Zhou ZH, Chen XS., Free PMC Article | 01/21/2023 |
| The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness. | The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.
Kim K, Calabrese P, Wang S, Qin C, Rao Y, Feng P, Chen XS., Free PMC Article | 10/22/2022 |
| The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside. | The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside.
Ma C, Liu P, Cui S, Gao C, Tan X, Liu Z, Xu R., Free PMC Article | 10/1/2022 |
| HIV-1 VIF and human APOBEC3G interaction directly observed through molecular specific labeling using a new dual promotor vector. | HIV-1 VIF and human APOBEC3G interaction directly observed through molecular specific labeling using a new dual promotor vector.
Myint W, Schiffer CA, Matsuo H., Free PMC Article | 07/9/2022 |
| Host Restriction Factor A3G Inhibits the Replication of Enterovirus D68 by Competitively Binding the 5' Untranslated Region with PCBP1. | Host Restriction Factor A3G Inhibits the Replication of Enterovirus D68 by Competitively Binding the 5' Untranslated Region with PCBP1.
Li Z, Yang X, Zhao Z, Liu X, Zhang W., Free PMC Article | 02/19/2022 |
| Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma. | Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.
Talluri S, Samur MK, Buon L, Kumar S, Potluri LB, Shi J, Prabhala RH, Shammas MA, Munshi NC., Free PMC Article | 02/5/2022 |
| Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2. | Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.
Meissner ME, Willkomm NA, Lucas J, Arndt WG, Aitken SF, Julik EJ, Baliga S, Mansky LM., Free PMC Article | 02/5/2022 |
| Activation-induced cytidine deaminase expression in patients with myelodysplastic syndrome and its relationship with prognosis and treatment | Activation-induced cytidine deaminase expression in patients with myelodysplastic syndrome and its relationship with prognosis and treatment.
Torun ES, Dağlar Aday A, Nalçacı M. | 01/1/2022 |
| STUB1/CHIP promotes ubiquitination and degradation of HIV-1 Vif to restore the cellular level of APOBEC3G protein. | STUB1/CHIP promotes ubiquitination and degradation of HIV-1 Vif to restore the cellular level of APOBEC3G protein.
Ali A, Kumar V, Banerjea AC. | 11/22/2021 |
| APOBEC3G rescues cells from the deleterious effects of DNA damage. | APOBEC3G rescues cells from the deleterious effects of DNA damage.
Botvinnik A, Shivam P, Smith Y, Sharma G, Olshevsky U, Moshel O, Manevitch Z, Climent N, Oliva H, Britan-Rosich E, Kotler M. | 11/13/2021 |
| A3G-induced mutations show a low prevalence and exhibit plus-strand regional distribution in hepatitis B virus DNA from patients with non-hepatocellular carcinoma (HCC) and HCC. | A3G-induced mutations show a low prevalence and exhibit plus-strand regional distribution in hepatitis B virus DNA from patients with non-hepatocellular carcinoma (HCC) and HCC.
Ren F, Li W, Zhao S, Wang L, Wang Q, Li M, Xiang A, Guo Y. | 10/9/2021 |
| Long non-coding RNA ESCCAL-1 promotes esophageal squamous cell carcinoma by down regulating the negative regulator of APOBEC3G. | Long non-coding RNA ESCCAL-1 promotes esophageal squamous cell carcinoma by down regulating the negative regulator of APOBEC3G.
Liu J, Mayekar MK, Wu W, Yan M, Guan H, Wang J, Zaman A, Cui Y, Bivona TG, Choudhry H, Xing Q, Cao W. | 03/28/2021 |
| Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains. | Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.
Maiti A, Myint W, Delviks-Frankenberry KA, Hou S, Kanai T, Balachandran V, Sierra Rodriguez C, Tripathi R, Kurt Yilmaz N, Pathak VK, Schiffer CA, Matsuo H., Free PMC Article | 03/6/2021 |
| Coronavirus genomes carry the signatures of their habitats. | Coronavirus genomes carry the signatures of their habitats.
Wei Y, Silke JR, Aris P, Xia X., Free PMC Article | 01/9/2021 |
| Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling. | Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.
Salamango DJ, McCann JL, Demir Ö, Becker JT, Wang J, Lingappa JR, Temiz NA, Brown WL, Amaro RE, Harris RS., Free PMC Article | 01/2/2021 |
| DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. | DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers.
Mas-Ponte D, Supek F., Free PMC Article | 10/31/2020 |